Henry M Jackson Foundation For The Advancement of Military Medicine

As trusted partners with military medical researchers, important HJF accomplishments include attracting, managing, and retaining highly qualified scientific staff to support the priorities of U.S. military medicine. Whether it is the senior scientist to lead major initiatives and work collaboratively with U.S. government scientists, or lab techs to perform ongoing research functions, HJF hired the best and brightest talent to accelerate innovations necessary to advance military medicine. HJF's work in FY2022 brought advances in battling the COVID-19 pandemic. HJF teams played a vital role in supporting research programs focused on COVID-19 vaccines and treatments since March 2020, based on decades of experience investigating infectious diseases worldwide. Other research initiatives widened HJF's reach across geographic regions, engaged new partners, resulted in patented technology, and strengthened collaborations across U.S. federal agencies, universities, non-governmental organizations, and private industry. Supported HJF Programs PEPFAR: Since 2005, HJF Medical Research International has implemented the U.S. President's Emergency Plan for AIDS Release (PEPFAR) HIV prevention, care and treatment services across four countries in Africa. In 2022, COVID vaccinations were given alongside a full slate of HIV programs. The One-Stop Shop model was convenient for patients to receive HIV counseling or preventative services as well as receive the COVID vaccination. Monkeypox Outreach and Training: The Walter Reed Institute of Research Emerging Infectious Diseases Branch, HJFMRI, U.S. Army Medical Research Directorate-Africa/Nigeria and collaborators in Nigeria completed monkeypox public outreach and sample collection training in 2022. The program provided comprehensive outbreak detection, case management, and public outreach training for 120 Nigerian human and animal healthcare workers. Prostate Cancer Research: In 2022, the Center for Prostate Disease Research at the Uniformed Services University of the Health Sciences developed a new approach to fighting prostate cancer. Researchers developed a potent new drug that could help treat a common type of prostate cancer that affects 50 to 65 percent of men. Creative Forces: HJF worked with a joint U.S. federal agency collaboration focused on creative arts therapies as a way of improving the health, wellness, and quality of life for military and veteran populations exposed to trauma as well as their families and caregivers. There are 12 Creative Forces sites located at DoD and VA medical treatment facilities across the United States that offer arts therapies through individual and group sessions delivered in-person as well as via telehealth. Hendra Virus Antibody Therapy: In Queensland, Australia, two people who were in close contact with a horse infected with the deadly Hendra virus were treated with an HJF-licensed antibody therapy, which is available for compassionate use. In FY22, HJF received more than 195 new awards, grants, agreements, or contracts in addition to the more than 13,850 it has administered since 1983. HJF had more than 1,100 active research protocols in process during FY22 across 17 countries, with approximately 3,000 teammates at sites on four continents.

Endowments delivered significant program services and support to the Uniformed Services University for the Health Sciences (USU), particularly for the School of Medicine and the clinical sciences Department of Surgery and Department of Dermatology. Programs include fellowship grants for graduate students studying military medicine at USU. HJF Fellowship Awards provide travel, education, and training support.

Education accounts provided educational, training, and other approved initiatives related to advancing military medicine. Samples of projects funded through educational initiatives include the provisioning of textbooks, travel to medical conferences or courses, support for exams, and manuscript publication expenses.